Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

“I’m Not a Good Drug Dealer”

Styles of Buprenorphine Diversion in a Multisite Qualitative Study

Bibliographic Data

ID21646737
AuthorsKatherine Mclean (0000-0002-2963-5064, Administration of Justice, Penn State Greater Allegheny, McKeesport, Pennsylvania, USA, corresponding author), P R Kavanaugh (0000-0001-7098-3880, School of Public Affairs, Penn State Harrisburg, Middletown, Pennsylvania, USA)
Year2022
Volume57
Issue3
Pages452-460
Publication date2022-02-23
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueSubstance Use & Misuse (JOURNAL)
Journal identifiersISSN: 1082-6084 • E-ISSN: 1532-2491
PublisherInforma UK Limited (PUBLISHER • GB)
DOI10.1080/10826084.2021.2019775
PMID35067160
OpenAlexW4207069935
LanguageEN
References cited21

BACKGROUND: Against the backdrop of the U.S. opioid epidemic, there has been a concerted movement to improve access to buprenorphine maintenance therapy (BMT). In Pennsylvania, where overdose mortality increased 65% between 2015 and 2017, over $75 million has been appropriated toward BMT since 2016. Concurrently, efforts to increase BMT availability while lowering barriers to entry have given way to fears of increased diversion and illegitimate patients. Little is known about the circumstances and motivations that surround buprenorphine diversion, particularly within the context of treatment expansion. METHOD: Drawing on 27 in-depth interviews with individuals who reported sharing or selling buprenorphine in the past year, in this study we consider the relationship between treatment access, treatment experiences, and individuals' decision to divert buprenorphine, while further comparing motivations for buprenorphine diversion across two Pennsylvania counties with disparate levels of BMT availability. RESULTS: We identify four styles of buprenorphine diversion ("ad hoc sellers," "concerned suppliers," "social sharers," "professional dealers"), with different levels of representation by county. Overall, our analysis found the explicit economic exploitation of BMT was rare, while a plurality of participants reported selling unwanted or unneeded buprenorphine only when presented with an opportunity. CONCLUSIONS: Across our typology, market demand in the form of unmet need for buprenorphine was the major driver of diversion, suggesting that "supply-side interventions" intended to again limit access to BMT may be counterproductive

Buprenorphine · Geography · Opioid · Psychiatry · Psychological intervention · Sociology · Typology · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes

  • “The Doctor Says You Cannot Have [Buprenorphine]” Autonomy and Use of Prescribed or Non-Prescribed Buprenorphine

    Benjamin T Hayes, Andrea Jakubowski et al.•Substance Use & Misuse•2021

  • Not what the doctor ordered

    Open Access•Tom May, Katy Holloway et al.•International Journal of Drug…•2020

  • They're making it so hard for people to get help

    Open Access•Katherine Mclean, P R Kavanaugh•International Journal of Drug…•2019

  • Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009

    Robert P Schwartz, Jan Gryczynski et al.•American Journal of Public Health•2013

Citation velocityhistorical
Highly citedNo

Tools

Open DOI
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae